{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:38:25Z","timestamp":1791898705043,"version":"4.3.4"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T00:00:00Z","timestamp":1084233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pigment Cell Research"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p>Human leukocyte antigen (HLA) class II associations with two subtypes of vitiligo: vitiligo vulgaris and halo nevi associated with vitiligo were investigated. In previous studies associations between vitiligo and HLA antigens have been reported but these two subtypes have never been taken into account. However from a clinical and histological point of view, a difference in (auto)\u2010immune pathogenesis can be expected. This difference might be reflected in an association with different HLA alleles. Seventy\u2010six unrelated Dutch Caucasians, 40 with vitiligo vulgaris and 36 with halo nevi associated with vitiligo were included. A panel of randomly chosen HLA typed healthy Dutch blood donors (n\u2003=\u20032400) served as control population. HLA\u2010DR and \u2010DQ typing was carried out on blood samples by amplifying genomic DNA using polymerase chain reaction followed by dot blot hybridization with sequence specific oligonucleotides. The main outcome measures were odds ratio (OR), uncorrected P\u2010value (P<jats:sub>u<\/jats:sub>) and corrected P\u2010value. There were distinct differences in the clinical manifestations between vitiligo vulgaris and halo nevi associated with vitiligo with respect to precipitating factors, extent and progress of the disease and the association with other auto\u2010immune diseases in the two subtypes and their respective first degree family members. Our stratification reveals differences in HLA class II between both subtypes and between subtypes and controls. A case\u2013control association study showed a significant positive association of HLA\u2010DR4 (OR\u2003=\u20032.787, P<jats:sub>u<\/jats:sub>\u2003=\u20030.0022) and DR53 (OR\u2003=\u20032.249, P<jats:sub>u<\/jats:sub>\u2003=\u20030.0153) and a negative association of HLA\u2010DR3 (OR\u2003=\u20030.195, P<jats:sub>u<\/jats:sub>\u2003=\u20030.0024) with vitiligo vulgaris. The group with halo nevi associated with vitiligo did not show these associations, but had a significant negative association with HLA\u2010DR11 (OR\u2003=\u20030.083, P<jats:sub>u<\/jats:sub>\u2003=\u20030.0067). In conclusion, the differences in HLA association within clinical subtypes of vitiligo support our suggestion that vitiligo vulgaris and halo nevi associated with vitiligo have distinct pathogenic mechanisms.<\/jats:p>","DOI":"10.1111\/j.1600-0749.2004.00145.x","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T08:51:22Z","timestamp":1084265482000},"page":"270-274","source":"Crossref","is-referenced-by-count":52,"title":["Difference in Pathogenesis Between Vitiligo Vulgaris and Halo Nevi Associated with Vitiligo is Supported by an HLA Association Study"],"prefix":"10.1111","volume":"17","author":[{"given":"Hannah C.","family":"De Vijlder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiete","family":"Westerhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geziena M. Th.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H. J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,11]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4615-9272-3","volume-title":"Vitiligo in: Vitiligo and Other Hypomelanosis of Hair and Skin","author":"Ortonne JP","year":"1983"},{"key":"e_1_2_9_3_2","first-page":"100","article-title":"Resultaten van een enqu\u00eate onder vitiligo pati\u00ebnten","volume":"6","author":"Westerhof W","year":"1996","journal-title":"Ned Tijdschr Dermatol en venereol"},{"key":"e_1_2_9_4_2","first-page":"981","article-title":"Genetic epidemiology of vitiligo: multilocus recessivity cross\u2010validated","volume":"55","author":"Nath SK","year":"1994","journal-title":"Am J Hum Gen"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/375451"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)80279-5"},{"key":"e_1_2_9_7_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archderm.1990.01670250062009","article-title":"Vitiligo is associated with HLA\u2010DR4 in black patients","volume":"126","author":"Dunston GM","year":"1990","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1155\/1993\/356874"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12614826"},{"key":"e_1_2_9_10_2","first-page":"90","article-title":"Linkage and association of HLA class II genes with vitiligo in a Dutch population","volume":"145","author":"Zamani M","year":"2001","journal-title":"Br J Med"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247240"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(91)90245-6"},{"key":"e_1_2_9_13_2","first-page":"23","article-title":"Vitiligo is associated with HLA\u2010A2 and HLA\u2010DW7 in the slovak populations","volume":"42","author":"Buc M","year":"1996","journal-title":"Folia Biol (Praha)"},{"key":"e_1_2_9_14_2","first-page":"13","article-title":"Occurrence rates of HLA\u2010DRB1, HLA\u2010DQB1 and HLA\u2010DPB1 Alleles in patients suffering from vitiligo","volume":"8","author":"Buc M","year":"1998","journal-title":"Eur J Dermatol"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1991.tb02984.x"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247426"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1995.tb01279.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.1995.tb00232.x"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1996.tb02670.x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(93)90143-O"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01348.x"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01285.x"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.1974.tb00312.x"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00023.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70181-6"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)80054-1"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.3.1789"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12274521"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00032.x"}],"container-title":["Pigment Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0749.2004.00145.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0749.2004.00145.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:11:06Z","timestamp":1697281866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0749.2004.00145.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,11]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1600-0749.2004.00145.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0749.2004.00145.x","archive":["Portico"],"relation":{},"ISSN":["0893-5785","1600-0749"],"issn-type":[{"value":"0893-5785","type":"print"},{"value":"1600-0749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,11]]}}}